menu
    • menu

    Company profile for Seqirus

    NEW Drugs in Dev: 24
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seqirus, formerly bioCSL, manufactures and in-licenses, markets and distributes vaccines with particular focus on vaccines for the prevention and treatment of serious disease. We operate one of the world’s largest influenza vaccine manufacturing facilities and supply seasonal influenza vaccines to Australia and global markets. In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now th...
    Seqirus, formerly bioCSL, manufactures and in-licenses, markets and distributes vaccines with particular focus on vaccines for the prevention and treatment of serious disease. We operate one of the world’s largest influenza vaccine manufacturing facilities and supply seasonal influenza vaccines to Australia and global markets. In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SeqirusAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    63 Poplar Road Parkville Victoria 3052
    Telephone
    Telephone
    +61 3 9389 2000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.seqirus.com.au/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
    FDA Proposes Febrile Seizure Warnings on Flu Shot Labels

    17 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-tells-sanofi-gsk-az-and-csl-include-warning-childhood-seizures-flu-shots

    FIERCE PHARMA
    17 Jan 2026
    Share Share
    RWE Shows Cell-Based Flu Vaccines Give 20% Higher Protection
    RWE Shows Cell-Based Flu Vaccines Give 20% Higher Protection

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/recent-rwe-data-show-cell-based-influenza-vaccines-offer-20-greater-protection-in-the-prevention-of-test-confirmed-influenza-in-pediatric-and-adult-populations-relative-to-standard-egg-based-influenza-vaccines-302590073.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    New Data Show Influenza Vaccines Comparable For Adults 65+
    New Data Show Influenza Vaccines Comparable For Adults 65+

    18 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-data-presented-at-idweek-2024-show-adjuvanted-and-high-dose-influenza-vaccines-are-comparable-in-protecting-adults-65-years-of-age-and-older-against-seasonal-influenza-302280334.html

    PR NEWSWIRE
    18 Oct 2024
    Share Share
    CSL Seqirus Present Data At IDWeek 2024 On Flu Vaccination Needs
    CSL Seqirus Present Data At IDWeek 2024 On Flu Vaccination Needs

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/csl-seqirus-presents-data-at-idweek-2024-highlighting-the-urgent-need-to-increase-influenza-vaccination-rates-and-the-benefits-of-cell-based-influenza-vaccines-302277865.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    Europe taps CSL Seqirus to produce bird flu vaccines
    Europe taps CSL Seqirus to produce bird flu vaccines

    12 Jun 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/eu-bulks-pre-pandemic-vaccine-stockpile-four-year-csl-seqirus-contract-40-million-bird-flu

    FIERCE PHARMA
    12 Jun 2024
    Share Share
    CSL Seqirus Gets US Award For Pandemic Preparedness, Avian Flu Response
    CSL Seqirus Gets US Award For Pandemic Preparedness, Avian Flu Response

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/csl-seqirus-a-proud-champion-of-pandemic-preparedness-announces-us-government-award-in-response-to-avian-influenza-302159392.html

    PR NEWSWIRE
    30 May 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search